UAB Digital Repository of Documents 12 records found  1 - 10next  jump to record: Search took 0.02 seconds. 
1.
7 p, 415.0 KB Growth differentiation factor 15 as mortality predictor in heart failure patients with non-reduced ejection fraction / Mendez Fernandez, Ana Belen (Institut d'Investigació Biomèdica Sant Pau) ; Ferrero-Gregori, Andreu (Institut d'Investigació Biomèdica Sant Pau) ; Garcia-Osuna, Álvaro (Institut d'Investigació Biomèdica Sant Pau) ; Mirabet-Perez, Sonia (Institut d'Investigació Biomèdica Sant Pau) ; Pirla-Buxó, Maria Jose (Institut d'Investigació Biomèdica Sant Pau) ; Cinca, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Ordoñez-Llanos, Jordi (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Roig Minguell, Eulàlia (Institut d'Investigació Biomèdica Sant Pau)
The prognostic value of biomarkers in patients with heart failure (HF) and mid-range (HFmrEF) or preserved ejection fraction (HFpEF) has not been widely addressed. The aim of this study was to assess whether the prognostic value of growth differentiation factor 15 (GDF-15) is superior to that of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with HFmrEF or HFpEF. [...]
2020 - 10.1002/ehf2.12621
ESC Heart Failure, Vol. 7 (june 2020) , p. 2223-2229  
2.
9 p, 3.3 MB Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes / de la Espriella, Rafael (Universitat de València) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; Morillas, Herminio (Hospital de Dénia-MarinaSalud) ; Bravo, Rafael (Hospital Costa del Sol) ; Vidal, Verónica (Hospital General de València) ; Núñez, Eduardo (Universitat de València) ; Santas, Enrique (Universitat de València) ; Miñana, Gema (Universitat de València) ; Sanchis, Juan (CIBER in Cardiovascular Diseases (CIBERCV)) ; Fácila, Lorenzo (Hospital General de València) ; Torres, Francisco (Hospital de Dénia-MarinaSalud) ; Górriz, Jose Luis (Universitat de València) ; Valle, Alfonso (Hospital de Dénia-MarinaSalud) ; Núñez, Julio (CIBER in Cardiovascular Diseases (CIBERCV))
The aim of this study was to evaluate the safety profile in terms of changes in renal function after co-treatment with sacubitril/valsartan and empagliflozin in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). [...]
2020 - 10.1002/ehf2.12965
ESC Heart Failure, Vol. 7 (september 2020) , p. 3792-3800  
3.
10 p, 563.7 KB Mortality risk prediction in elderly patients with cardiogenic shock : results from the CardShock study / Hongisto, Mari (Helsinki University Hospital) ; Lassus, Johan (Helsinki University Hospital) ; Tarvasmäki, Tuukka (Helsinki University Hospital) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Sans-Rosello, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Tolppanen, Heli (Helsinki University Hospital) ; Kataja, Anu (Helsinki University Hospital) ; Jäntti, Toni (Helsinki University Hospital) ; Sabell, Tuija (Helsinki University Hospital) ; Lindholm, Matias Greve (Zealand University Hospital) ; Banaszewski, Marek (National Institute of Cardiology) ; Silva Cardoso, Jose (University of Porto, São João University Medical Centre) ; Parissis, John (Attikon University Hospital) ; Di Somma, Salvatore (Sapienza University of Rome) ; Carubelli, Valentina (University and Civil Hospital of Brescia) ; Jurkko, Raija (Helsinki University Hospital) ; Masip, Josep (Hospital Sant Joan Despi Moisès Broggi, Consorci Sanitari Integral, University of Barcelona) ; Harjola, Veli-Pekka (Helsinki University Hospital) ; Universitat Autònoma de Barcelona
This study aimed to assess the utility of contemporary clinical risk scores and explore the ability of two biomarkers [growth differentiation factor-15 (GDF-15) and soluble ST2 (sST2)] to improve risk prediction in elderly patients with cardiogenic shock. [...]
2021 - 10.1002/ehf2.13224
ESC Heart Failure, Vol. 8 (january 2021) , p. 1398-1407  
4.
3 p, 226.3 KB Intrarenal venous flow in cardiorenal syndrome : a shining light into the darkness / de la Espriella-Juan, Rafael (CIBER in Cardiovascular Diseases (CIBERCV)) ; Núñez, Eduardo (CIBER in Cardiovascular Diseases (CIBERCV)) ; Miñana, Gema (CIBER in Cardiovascular Diseases (CIBERCV)) ; Sanchis, Juan (CIBER in Cardiovascular Diseases (CIBERCV)) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; González, Jessika (CIBER in Cardiovascular Diseases (CIBERCV)) ; Chorro, Javier (CIBER in Cardiovascular Diseases (CIBERCV)) ; Núñez, Julio (CIBER in Cardiovascular Diseases (CIBERCV))
The aim of this case report is to assess the potential role of intrarenal Doppler ultrasonography as a non-invasive method to evaluate intrarenal venous flow (IRVF) in acute heart failure (AHF) and concomitant renal dysfunction. [...]
2018 - 10.1002/ehf2.12362
ESC Heart Failure, Vol. 5 (october 2018) , p. 1173-1175  
5.
8 p, 326.6 KB Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction / Santas, Enrique (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; de la Espriella, Rafael (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; Palau, Patricia (Hospital General de Castellón, Universitat Jaume I) ; Miñana, Gema (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; Amiguet, Martina (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; Sanchis, Juan (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; Lupón, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Chorro, Francisco Javier (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; Núñez Villota, Julio (Hospital Clínico Universitario, Universitat de València, INCLIVA, CIBERCV) ; Universitat Autònoma de Barcelona
Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risks over time remains unclear. [...]
2020 - 10.1002/ehf2.12683
ESC Heart Failure, Vol. 7 (march 2020) , p. 1007-1014  
6.
6 p, 288.0 KB Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock / Sabell, Tuija (Helsinki University Hospital, Helsinki University) ; Banaszewski, Marek (Institute of Cardiology) ; Lassus, Johan (Helsinki University Hospital, Helsinki University) ; Nieminen, Markku S. (Helsinki University Hospital, Helsinki University) ; Tolppanen, Heli (Helsinki University Hospital, Helsinki University) ; Jäntti, Toni (Helsinki University Hospital, Helsinki University) ; Kataja, Anu (Helsinki University Hospital, Helsinki University) ; Hongisto, Mari (Helsinki University Hospital, Helsinki University) ; Køber, Lars (Rigshospitalet, University of Copenhagen) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Parissis, John (Attikon University Hospital) ; Tarvasmäki, Tuukka (Helsinki University Hospital, Helsinki University) ; Harjola, Veli-Pekka (Helsinki University Hospital, Helsinki University) ; Jurkko, Raija (Helsinki University Hospital, Helsinki University) ; Universitat Autònoma de Barcelona
Urgent revascularization is the mainstay of treatment in acute coronary syndrome (ACS) related cardiogenic shock (CS). The aim was to investigate the association of angiographic results with 90-day mortality. [...]
2020 - 10.1002/ehf2.12637
ESC Heart Failure, Vol. 7 (march 2020) , p. 768-773  
7.
8 p, 940.6 KB Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure : a pilot study / Revuelta-López, Elena (Institut Germans Trias i Pujol) ; Núñez, Julio (Hospital Clínico Universitario, Universitat de València, INCLIVA) ; Gastelurrutia, Paloma (Institut Germans Trias i Pujol) ; Januzzi, James L. (Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research) ; Ibrahim, Nasrien E. (Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research) ; Emdin, Michele (Scuola Superiore Sant'Anna, Fondazione Toscana Gabriele Monasterio) ; VanKimmenade, Roland (Radboud University Medical Centre) ; Pascual-Figal, Domingo (Universidad de Murcia) ; Núñez, Eduardo (Hospital Clínico Universitario, Universitat de València, INCLIVA) ; Gommans, Frank (Radboud University Medical Centre) ; Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
Sacubitril/valsartan is a first-in-class angiotensin receptor-neprilysin inhibitor developed for the treatment of heart failure with reduced ejection fraction. Its benefits are achieved through the inhibition of neprilysin (NEP) and the specific blockade of the angiotensin receptor AT1. [...]
2020 - 10.1002/ehf2.12607
ESC Heart Failure, Vol. 7 (february 2020) , p. 559-566  
8.
11 p, 2.8 MB Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines : The Linx Registry / de Frutos, Fernando (Hospital Universitari de Bellvitge) ; Mirabet, Sonia (Institut d'Investigació Biomèdica Sant Pau) ; Ortega-Paz, Luis (Department of Cardiology, Hospital Clinic) ; Buera, Irene (Department of Cardiology, Hospital de Viladecans) ; Darnés, Sara (Department of Cardiology, Hospital de Figueres) ; Farré, Nuria (Institut Hospital del Mar d'Investigacions Mèdiques) ; Perez, Bernardo (Hospital de Granollers) ; Adeliño, Raquel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bascompte, Ramón (Hospital Universitari Arnau de Vilanova) ; Pérez-Rodón, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aparicio, Xavier (Hospital de Mataró) ; Sutil-Vega, Mario (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Soto, Adriana (Hospital de Martorell) ; Faraudo, Mercedes (Hospital Moises Broggi) ; Cainzos-Achirica, Miguel (Hospital Universitari de Bellvitge) ; Manito, Nicolás (Hospital Universitari de Bellvitge) ; Universitat Autònoma de Barcelona
In May 2016, a new version of the European Society of Cardiology (ESC) Guidelines for the management of heart failure (HF) was released. The aim of this study was to describe the management of HF with reduced ejection fraction after the publication of ESC Guidelines. [...]
2020 - 10.1002/ehf2.12567
ESC Heart Failure, Vol. 7 (january 2020) , p. 25-35  
9.
8 p, 164.5 KB Determination of HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in heart failure patients / Rudilla, F (Institut Germans Trias i Pujol) ; Rudilla, F. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gastelurrutia, Paloma (Institut Germans Trias i Pujol) ; Enrich, E. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Campos, E. (Histocompatibility and Immunogenetics Laboratory. Blood and Tissue Bank) ; Lupón, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Santiago-Vacas, E. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Querol, S. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Aims: Cell therapy can be used to repair functionally impaired organs and tissues in humans. Although autologous cells have an immunological advantage, it is difficult to obtain high cell numbers for therapy. [...]
2019 - 10.1002/ehf2.12406
ESC Heart Failure, Vol. 6 Núm. 2 (april 2019) , p. 388-395  
10.
5 p, 173.0 KB Circulating levels of 423-5p are associated with 90 day mortality in cardiogenic shock / Jäntti, Toni (Department of Internal Medicine, University of Helsinki and Helsinki University Hospital) ; Segersvärd, Heli (Minerva Foundation Institute for Medical Research and University of Helsinki) ; Tolppanen, Heli (Department of Cardiology, University of Helsinki and Heart and Lung Center, Helsinki University Hospital) ; Tarvasmäki, Tuukka (Department of Cardiology, University of Helsinki and Heart and Lung Center, Helsinki University Hospital) ; Lassus, Johan (Department of Cardiology, University of Helsinki and Heart and Lung Center, Helsinki University Hospital) ; Devaux, Yvan (Luxembourg Institute of Health) ; Vausort, Mélanie (Luxembourg Institute of Health) ; Pulkki, Kari (Department of Clinical Chemistry, University of Eastern Finland and Eastern Finland Laboratory Centre (ISLAB)) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tikkanen, Ilkka (Division of Nephrology, University of Helsinki and Abdominal Center, Division of Nephrology, Helsinki University Hospital) ; Lakkisto, Päivi (Department of Clinical Chemistry, University of Helsinki and Department of Clinical Chemistry, Helsinki University Hospital) ; Harjola, Veli-Pekka (Division of Emergency Medicine, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital) ; Universitat Autònoma de Barcelona. Departament de Medicina
The role of microRNAs has not been studied in cardiogenic shock. We examined the potential role of miR-423-5p level to predict mortality and associations of miR-423-5p with prognostic markers in cardiogenic shock. [...]
2018 - 10.1002/ehf2.12377
ESC Heart Failure, Vol. 6 (november 2018) , p. 98-102  

UAB Digital Repository of Documents : 12 records found   1 - 10next  jump to record:
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.